No abstract available
MeSH terms
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects
-
Carcinoma, Non-Small-Cell Lung / blood
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / immunology
-
Cryoglobulinemia / chemically induced
-
Cryoglobulinemia / immunology
-
Humans
-
Lung Neoplasms / blood
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / immunology
-
Male
-
Middle Aged
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / immunology
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab